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Background: Clinical guidelines for type 2 diabetes are a resource for providers to manage their patients and
may help highlight specific areas in need of further education and training. We sought to determine how often
guidelines are used and the relationship to physicians’ diabetes-related knowledge and decision making.
Methods: Existing users of electronic clinical support tools were invited to complete an online questionnaire.
A knowledge score was calculated for five questions related to prevention of diabetes and treatment of its
complications. We explored the association of clinical guideline use with diabetes-related knowledge and
self-reported decision making using logistic regression models, adjusted for key covariates.
Results: Of 383 physicians completing the questionnaire, 53% reported using diabetes guidelines routinely. Mean
diabetes knowledge score for guideline users (GU) was significantly higher than non-guideline users (NGU) (3.37 ± 0.072
vs. 2.76 ± 0.084; p < 0.001). GU were significantly more likely to report a good understanding of type 2 diabetes
medications (OR = 2.99, 95% CI 1.95-4.61; p < 0.001). GU were less likely to report their unfamiliarity with insulin as
an important barrier to early insulin use (OR = 0.41, 0.21-0.80; p = 0.007) and with pharmacologic options as a barrier to
prescribing intensive multifactorial interventions (OR = 0.32, 0.17-0.58; p < 0.001). Associations remained significant after
adjusting for physician specialty, practice volume and frequency diagnosing or treating diabetes patients.
Conclusions: Significant gaps exist in diabetes-related knowledge and decision making among practicing physicians,
as highlighted by clinical guideline use. The development of educational and training strategies to address these needs
may ultimately improve outcomes for patients with diabetes and should be investigated in the future.
Keywords: Diabetes, Clinical Guidelines, EducationBackground
The number of persons with diabetes continues to rise,
with about 29 million Americans or 9.3% of the U.S.
population having diabetes [1]. Estimates project that this
number will nearly double over the next 25 years [2,3].
With the rising prevalence of diabetes, it is imperative that
physicians be familiar with the currently recommended
standards of care regarding the prevention, diagnosis and
treatment of diabetes in order to not only appropriately
manage patients with the disease but also reduce the public
health impact of diabetes and its complications on society.* Correspondence: rrastogi@jhmi.edu
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unless otherwise stated.Consequently, there exists a need for physicians to be
well-trained in the care of patients with diabetes. The
best educational methods to achieve this competency
are not clearly established. Internal medicine training
programs may not fully achieve this important educational
objective. A study by our group found that internal
medicine residency programs across the U.S. only modestly
improve diabetes-related knowledge during training and
many residents continue to have significant knowledge
gaps in the last year of their training program [4]. Another
study sampled over 2,000 physicians about their training in
diabetes management. Two-thirds of participants reported
that their training did not adequately prepare them to
optimize diabetes treatments and indicated a need for
further training in all aspects of diabetes care [5]. Similarl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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Kingdom survey by the same investigators. In this study,
relatively recent medical school graduates were surveyed.
Less than a quarter of physicians reported having full
confidence that they could diagnose diabetes and only
15% reported that they would always optimize glycemic
control in their practice [6]. These studies suggest that
current educational methods may result in significant
gaps in physician knowledge of diabetes management at
the completion of formal medical training.
Further, in clinical practice, many patients with diabetes
are still not achieving suggested guideline goals [7,8]. A
recent study demonstrated suboptimal attainment of the
American Diabetes Association’s recommended targets
in the U.S. population [9]. Based on National Health and
Nutrition Examination Survey data from 2007–2010,
among persons with diabetes, only 52.5% achieved an
HbA1c < 7%, 51.1% achieved a blood pressure <130/80
mmHg, 56.2% achieved an LDL <100 mg/dL, and only
18.8% achieved all three goals [10]. Thus, the recom-
mended standards of care are currently not being attained
for the majority of patients with diabetes and inconsistent
use of clinical guidelines by health care providers may be
one of the many potential reasons [11].
Clinical practice guidelines may serve as an educational
resource for physicians to improve their knowledge of
diabetes management and optimize patient outcomes in
clinical practice. Many societies publish and regularly
update clinical guidelines for diabetes, including the
American Diabetes Association, European Association
for the Study of Diabetes, and the American Association
of Clinical Endocrinologists [7,9,12-14]. These guidelines
synthesize available evidence-based information with
expert opinion to develop consensus recommendations
for health care providers. Although clinical guidelines
for diabetes are intended as an important resource for
providers to achieve the standard of care for their
patients with diabetes, the relationship of guideline use
to diabetes-related knowledge and decision making by
providers has not been formally described in previous
studies but can potentially help identify areas of need
for further training and continuing diabetes education.
Thus, the objectives of our study were to: 1) identify the
frequency of clinical diabetes guideline use in a cohort of
practicing physicians; 2) explore the association of clinical
guideline use with diabetes-related knowledge and deci-
sion making by providers; and 3) describe the degree to
which these relationships are independent of providers’
specialty, practice size, and diabetes patient volume.
Methods
Study population
The Point-of-Care Information Technology (POC-IT)
Guides are electronic evidence-based resources on varioustopics for practicing physicians to use in clinical decision
making. As part of a generalized needs assessment prior
to the development of a specialized electronic resource for
diabetes, a survey was developed to identify areas of need
for diabetes-related education among users in this existing
database. The database was comprised of any health care
provider that had previously registered for use of a POC-
IT Guide resource. Respondents were queried about their
frequency of use of consensus guidelines for diabetes
management in their practice. Additionally, participants
were asked to respond to a series of knowledge-based
questions related to diabetes and its complications and
questions related to their clinical decision making. There
was no financial or other incentive for participants to
complete the study questionnaire.
Questionnaire invitations were emailed to potential
participants as part of a needs assessment in January
2011 and were completed by July 31, 2011. Invitations
were sent to all registered users in the database (~80,000
users) without a priori knowledge of which of these
registrants actually treated patients with diabetes in
their practice and which registrants were physicians. In
addition, we could not confirm that invitation emails
were successfully received by users. Thus, to improve
response rate, reminder emails were sent periodically to
all users of the database. A total of 1,279 persons visited
the survey website. Of these individuals, 655 participants
fully completed the questionnaire and 238 participants
partially completed the questionnaire and reported treat-
ing patients with diabetes in their practice. Of those
who fully completed and submitted the questionnaire, 270
were other types of health care providers (nurses, podia-
trists, dieticians, pharmacists, and other) and excluded. In
the following study, we focused on the remaining physician
respondents given that we were interested in exploring
therapeutic decision-making by providers, as well. The
database of registrants includes health care providers who
manage multiple chronic diseases; diabetes is only one of
these diseases. Also, other allied health professionals in
addition to physicians were in the database. This partially
accounts for what appeared to be a low overall response
rate; nonetheless, the relatively large number of invitations
was necessary to effectively recruit physicians that manage
patients with diabetes for our study. Yet, the number of
physician participants recruited for our study was still
relatively large compared other studies exploring clinical
guideline use [15,16]. Among physician respondents that
submitted the questionnaire, 2 participants had missing
information for the question regarding the use of clinical
guidelines, resulting in 383 participants for our study.
All respondents care for patients with diabetes in their
practice.
The study was approved by the Institutional Review
Board at Johns Hopkins University School of Medicine.
Corriere et al. BMC Medical Education 2014, 14:186 Page 3 of 7
http://www.biomedcentral.com/1472-6920/14/186Questionnaire content
Respondents were asked in a multiple choice questionnaire
about their familiarity with the most recent consensus
guidelines for diabetes at the time including the American
Association of Clinical Endocrinologists (AACE) roadmap
and/or the American Diabetes Association/European Asso-
ciation for the Study of Diabetes (ADA/EASD) algorithm
[7,12]. Based on their selection of five possible answers,
participants were dichotomized as guideline users or
non-guideline users. Guideline users (GU) answered that
“either the algorithm or the roadmap is deeply integrated
into my practice” or “I have studied these guidelines and
occasionally refer to them”. Non-guideline users (NGU)
answered “I am unfamiliar with the specific content”, “I
am aware they exist but they don’t apply to real world
patient management”, or “I manage each patient as an
individual and do not rely on these guidelines”. While the
consensus guidelines referenced in the survey include
sections for the management all types of diabetes, the
focus of our study was on type 2 diabetes given that this
represents the majority (>95%) of cases [1]. Thus, the
survey questions focused primarily on the management of
type 2 diabetes in adults although some of the diabetes-
related knowledge questions may be common to other
types. The Additional files 1 and 2 provide the full know-
ledge and clinical decision making questions that were in-
cluded in this study which is in addition to the other
questions described below regarding participant specialty,
patient volume, and frequency treating patients with
diabetes. Other survey questions related to management
of prediabetes, suggested topics for future continuing
medical education, or for which there were no clear
consensus guidelines were not analyzed in our study. In
total, the responses to 16 survey questions served as
the basis for the results of our study.
Diabetes-related knowledge was assessed using five
questions on key topics related to diabetes and its
complications. These specific questions were chosen to
identify areas of potential need for continuing diabetes
education in the future. These questions assessed: [1]
knowledge of the findings from the United Kingdom
Prospective Diabetes Study, [2] recognition of the im-
portance of early diagnosis and treatment in preventing
complications, [3] identification of risk factors for diabetic
foot ulcers, [4] knowledge of glycemic goals in critically
ill patients, and [5] understanding the time course of
progression from prediabetes to diabetes (Additional file 1).
Each survey respondent received a “knowledge score”
from 0 to 5 based on the number of these questions
they answered correctly. Survey respondents that did
not complete all five questions were excluded from the
knowledge score assessment.
To characterize how physician participants’ use of clinical
guidelines relates to management of patients with diabetes,the questionnaire also included multiple-choice questions
about clinical decision making and use of diabetes ther-
apies (Additional file 2). Physicians were asked about
decisions related to use of early insulin and barriers to
their implementation of multifactorial intensive treatments
for patients. Lastly, physicians were asked about their
familiarity with currently available diabetes treatments
and use in their practice.
Physician participants also reported their specialty and
characteristics of their clinical practice with multiple
choice questions. Possible specialty responses were “pri-
mary care”, “endocrinology” or “other”. Practice volume
was assessed with a multiple choice question about the
number of patients seen on average each month in a
physician’s outpatient practice. “High” volume practices
were defined as physicians who reported > 250 patients
each month (i.e. the participant selected one of the
following options: 251–500, 501–750, or more than 750
patients) while “low” volume practices were defined as
physicians who reported ≤ 250 patients each month (i.e.
options selected were either less than 100 or 100–250
patients). The frequency of treating patients with diabetes
was assessed with a number of questions. This included
how frequently the physician made a new diagnosis of
type 2 diabetes. A “high” frequency of making new dia-
betes diagnoses was defined as physicians who reported
one or more new diagnoses a week (i.e. 1–3 times per
week or more than 3 times per week). A “low” frequency
of making new diabetes diagnoses was defined as physi-
cians who reported less than one new diagnosis a week
(i.e. less than once a week, less than once a month, or
rarely if ever). Physicians were asked how often they
treated patients with established diabetes in their practice.
A “high” frequency of treating established diabetes patients
was defined as physicians who reported ≥ 5 diabetes
patients a week (i.e. 5–10 times per week, 11–20 times
per week, or more than 20 times per week). A “low”
frequency of treating established diabetes patients was
defined as physicians who reported < 5 diabetes patients a
week (i.e. less than 5 times per week or rarely if ever).
Finally, physician participants were asked about how
often they provided care to hospitalized patients with
type 2 diabetes. The providers were dichotomized as
“high” if they chose “often” or “very often” for treating
hospitalized diabetes patients or “low” if they chose “never”
or “seldom” for treating hospitalized diabetes patients.
Statistical analysis
Clinical characteristics of guideline versus non-guideline
users were compared using chi-squared test for binary
outcomes. In addition, mean diabetes-related knowledge
scores were compared using student’s t test for continuous
outcomes. For purposes of analyses, and because there
were fewer responses in the extreme categories, ordinal
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for the size of practice and frequency of diabetes care
questions as described. Logistic regression models were
created to explore the association of clinical guideline
use with diabetes decision making both before and after
adjustment for physician specialty, practice volume, and
frequency diagnosing and treating patients with diabetes.
All analyses were performed using Stata version 12 statis-
tical software (College Station, Texas).
Results
Based on responses to the questionnaire among 383
participants, 53% of the physicians were categorized as
guideline users (GU) and 47% as non-guideline users
(NGU). Baseline characteristics of GU vs. NGU are shown
in Table 1. GU and NGU included a similar proportion of
primary care physicians but there were more endocrinolo-
gists among GU (GU 7.7% vs. NGU 2.2%, p = 0.01) and
more physicians from “other” subspecialties among NGU
(NGU 51.1% vs. GU 36.1%, p = 0.003).
Practice volume, frequency of treating patients with
established diabetes and frequency of treating hospitalized
patients with diabetes was similar among both groups.





users (n = 180)
p-value
Specialty
Primary care 56.1% 46.7% 0.07
Endocrinology 7.7% 2.2% 0.01
Other 36.1% 51.1% 0.003
Practice volume*














High 50.5% 51.1% 0.90
Low 49.5% 48.9%
*High volume >250 patients a month, **High frequency ≥ 1 diagnosis a week,
†High frequency ≥ 5 established diabetes patients a week, ‡High frequency
treating hospitalized patients as “often” or “very often”.at a high frequency (37.1% of GU vs. 22.8% of NGU,
p = 0.002).
Overall, the mean diabetes knowledge score was
higher among GU versus NGU (3.37 vs. 2.76, p < 0.001,
n = 364). Among individual questions, only the question
about risk factors for diabetic foot ulcers had a similar
proportion of correct responses among GU versus NGU.
Otherwise, GU had a significantly higher proportion of
correct responses to all of the knowledge questions
compared to NGU. Specifically, three-quarters of GU
correctly identified that the UKPDS demonstrated a
decrease in microvascular complications while only half
of NGU correctly answered this question (p < 0.001).
Further, 34.3% of GU compared to 24.1% of NGU cor-
rectly identified a target glucose goal range of 140–180
mg/dl among critically ill patients (p = 0.03). Also, GU
were more likely than NGU to answer correctly that
early diagnosis and treatment of diabetes can help pre-
vent complications (GU 78.4% vs. 66.8%, p = 0.01) and
that prediabetes is commonly present for a few years
(>24 months) before it progresses to diabetes (GU 54.6%
vs. NGU 44.4%, p = 0.046).
Overall, 67.3% of GU reported that they “somewhat”
or “completely” understood the available diabetes medi-
cines in their practice while only 40.7% of NGU reported
a similar understanding of diabetes medications in their
practice (p < 0.001).
A similar proportion of GU versus NGU reported fre-
quently prescribing early insulin treatment (i.e., more
than 20% of the time) in patients on 1–2 oral agents with
a hemoglobin A1c (HbA1c) >8% (GU 36.5% vs. NGU
28.2%, p = 0.09; n = 367). When asked about barriers to
early initiation of insulin therapy in their practice, both
groups had similar responses regarding patient factors
(i.e., patient resistance, patient concerns about dosing
regimens, inadequate resources for patient education
and monitoring, and patients’ perception that insulin
therapy represents disease progression). However, about a
quarter of NGU reported that their own unfamiliarity with
insulin was a significant barrier to early initiation (selected
within the top three barriers) while a significantly smaller
proportion of the GU group identified this as a significant
barrier to early initiation of insulin therapy (GU 12.7% vs.
NGU 26.1%, p = 0.009).
Participants were also asked to report reasons they
might not adopt an intensive, multi-factorial approach
to diabetes care, such as intensive lipid, blood pressure
and glycemic control. A larger proportion of NGU reported
unfamiliarity with pharmacologic options as one of the
reasons they would not adopt an intensive multifactorial
approach in their practice (GU 8.3% vs. NGU 22.2%,
p < 0.001).
Table 2 displays logistic regression models exploring the
relationship of clinical guideline use to diabetes-related
Table 2 Logistic regression models (Odds ratios and 95% confidence intervals) exploring the relationship of clinical
guideline use to diabetes-related knowledge and clinical decision making
Physician responses Unadjusted model Adjusted model*
Good understanding of diabetes medications in their practice 2.99 (1.95-4.61) 2.80 (1.79-4.39)
Unfamiliarity with insulin as a barrier to early insulin initiation 0.41 (0.21- 0.80) 0.37 (0.18-0.76)
Unfamiliarity/inexperience with pharmacologic options as a
barrier to adopting intensive multi-factorial interventions
0.32 (0.17- 0.58) 0.33 (0.17-0.62)
*Adjusted for physician specialty, practice volume and frequency diagnosing and treating patients with diabetes.
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models (model 1), GU versus NGU were three times
more likely to report a good (“completely” or “somewhat”)
understanding of currently available diabetes medica-
tions than NGU (OR = 2.99, 95% CI 1.95-4.39, p < 0.001;
n = 362); participants who chose “none of the above apply
to my practice” were not included in this analysis. Among
those participants that ranked all potential barriers to
early insulin initiation, GU compared to NGU were 59%
less likely to indicate unfamiliarity with insulin as an
important barrier to early insulin initiation (OR = 0.41,
0.21-0.80, p = 0.007, n = 243) and 68% less likely to report
unfamiliarity/inexperience with pharmacologic options as
a reason for not adopting an intensive multifactorial
approach (blood pressure treatment, lipid treatment,
glucose control) (OR = 0.32, 0.17-0.58, p < 0.001, n = 371).
All these findings were largely unchanged and remained
statistically significant in adjusted logistic regression models
that accounted for physician specialty, practice volume and
frequency diagnosing and treating patients with diabetes
(model 2).
In sensitivity analysis including only primary care
physician respondents (n = 199), we observed similar
associations regarding knowledge scores and clinical
decision making. Specifically, diabetes related know-
ledge scores remained significantly higher among GU
versus NGU. Physician unfamiliarity/inexperience with
pharmacologic options was also more commonly reported
as a barrier to adopting intensive multi-factorial interven-
tions among NGU compared to GU, and the differences
remained statistically significant.
Discussion
In the present study, we report that significant gaps in
diabetes-related knowledge and familiarity with diabetes
therapies exist in practicing physicians. Strikingly, there
existed a low level of diabetes-related knowledge among
both guideline and non-guideline users. However, clinical
guideline use was associated with significantly better
diabetes-related knowledge. Also, guideline users reported
greater familiarity with currently available treatments
for diabetes and clinical decision making that was more
consistent with currently recommended standards of care,
independent of specialty and clinical practice characteris-
tics. The demonstrated differences in diabetes-relatedknowledge and clinical decision making according to use
of clinical guidelines helps highlight important areas of
ongoing educational need among practicing physicians.
Clinical guidelines may serve as an educational resource
for health care providers who manage patients with dia-
betes. The use of clinical guidelines as educational tools has
been investigated for general medical conditions. Grimshaw
and colleagues performed a systematic review to assess the
impact of clinical guideline use on general medical practice
[17]. He concluded that explicit guidelines do improve
clinical practice but with considerable variations in per-
formance. Other educational tools that improve knowledge
have also been shown to positively affect clinical outcomes
in small studies of physicians who care for patients with
diabetes [18,19]. The DIABEDS trial demonstrated that a
physician education program among internal medicine
residents could lead to objective improvements in fasting
glucose, HbA1c, and body weight among their patients
[20]. Similar findings have been shown among practicing
community physicians who, in another study, participated
in a physician education project and subsequently demon-
strated an improvement in the frequency of HbA1c testing
and, eventually, overall mean HbA1c values among their
diabetes patients [21]. Our study only focused on surro-
gates of diabetes knowledge and decision making patterns.
We did not attempt to demonstrate improved patient
outcomes from use of clinical guidelines. Further inter-
ventional studies are needed to explore if clinical guidelines
and/or other possible educational tools (i.e., diabetes cur-
riculum development for medical trainees or continuing
medical education programs for practicing physicians) can
address the knowledge gaps identified by our study and
ultimately improve outcomes for patients with diabetes.
There may be many potential pathways by which clin-
ical guideline use, in particular, could be associated with
improved diabetes-related knowledge and decision making.
It is possible that the guidelines themselves impart
physician readers with improved knowledge and decision
making skills. In fact, we found that clinical guideline users
had higher diabetes-related knowledge scores compared to
non-guideline users in our study. Physician specialty and
practice characteristics may also be contributing factors.
Specialists (i.e., endocrinologists) may be more likely to
adhere to guidelines published by their professional soci-
eties than primary care physicians [11]. Physicians that see
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caring for such patients and/or have a stronger need to be
up-to-date with clinical guidelines for this disease. However,
we found that associations of clinical guideline use with
better diabetes-related knowledge and decision making
persisted even after accounting for physician specialty and
clinical practice characteristics.
The strengths of our study include the relatively large
number of participants examined and inclusion of both
primary care and specialist physicians, in comparison to
other studies on clinical guideline use [15,16]. We also
assessed a spectrum of disease-specific knowledge from
diabetes prevention and treatment to management of long-
term complications. In addition, we investigated the rela-
tionship of clinical guideline use to both gaps in physician
knowledge and also clinical decision making which further
extended our findings and have not previously been
reported in the literature. Finally, we were able to examine
providers’ familiarity with currently available diabetes
treatments such as early initiation of insulin therapy and
implementation of multifactorial interventions that remain
relevant to modern practice and guidelines [9,14].
Our study has limitations. First, the cross-sectional
design does not allow us to infer temporality. Indeed, the
reverse association is possible; physicians with improved
baseline knowledge may seek out educational resources
and be more likely to use clinical guidelines. However, we
were interested in the association of clinical guideline use
with diabetes-related knowledge and decision making, as
clinical guidelines may represent an educational tool that
could be used in the future. We dichotomized participants
as guideline users versus non-guideline users based on
their responses; only those that reported using clinical
guidelines in their practice were included in the guideline
user category. It is possible that some unrecognized famil-
iarity of guidelines was also present in the NGUs but
this would have overestimated knowledge scores of this
group and limited our ability to detect associations. Also,
residual confounding is possible. We did not have infor-
mation about physicians’ demographic characteristics or
geographic location of practice. However, previous studies
have had mixed results and not consistently demonstrated
that these factors are related to clinical guideline use in
other specialties [22,23]. Characterizing the individual
participant characteristics associated with diabetes clinical
guideline use was not the focus of our study, but may be
interesting to examine in the future. In addition, physicians’
attitudes or motivation due to other factors may influence
decision making, irrespective of their use of clinical guide-
lines [24,25], yet, we still found significant relationships
in our study. The inclusion of endocrinologists as well
as primary care physicians may have resulted in a more
heterogeneous study population and limited power;
however, we still detected significant associations andfound that results were similar when restricted to only
primary care physicians in sensitivity analyses suggesting
consistency of associations within each specialty. Also, the
knowledge score was not designed to be a comprehensive
assessment of a participants’ diabetes-related knowledge
but instead to identify areas of potential educational need.
The source of our study sample may also represent a
limitation. All subscribers to an online clinical decision-
making program were invited to participate without a
priori knowledge of which registrants of the database
routinely manage patients with diabetes. There was no
financial or other incentive for participants to complete the
study questionnaire. The database of registrants includes
other providers in addition to physicians who manage
multiple chronic diseases; diabetes is only one of these
diseases. This partially accounts for what appeared to
be a low overall response rate; yet, the relatively large
number of invitations was imperative in order to recruit
an adequate number of physicians that care for patients
with diabetes which was comparatively larger than other
studies [15,16]. Consequently, selection bias may limit
generalizability of our findings.
The survey tool we utilized has not yet been validated but
should be more critically examined in studies specifically
designed for this purpose. However, our study nonetheless
provides exploratory findings that can be further investi-
gated in representative populations of diabetes providers in
the future. Given the absence of other literature regarding
current gaps in diabetes-related knowledge among prac-
ticing physicians or the relationship of diabetes clinical
guideline use to providers’ familiarity with diabetes therap-
ies and clinical decision making, our study remains inform-
ative and provides findings that have not been previously
reported.
Conclusion
Our study demonstrates a significant gap in diabetes-
related knowledge and familiarity with existing therapies
among practicing physicians. The use of clinical diabetes
guidelines as a potential educational resource was associ-
ated with better diabetes-related knowledge and clinical
decision making that was more consistent with consensus
recommendations among physicians in our study. The
clinical care of patients with diabetes often uses a team
care approach involving not only the physician but also
nurse practitioners, physician assistants, practice facilita-
tors, and medical assistants who may also refer to consen-
sus guidelines. Future studies should explore potential
knowledge gaps in these other specialties. Nonetheless,
the findings of our study suggest the need for improved
continuing medical education among practicing physi-
cians and potentially training in diabetes management and
treatment. Intervention studies that investigate the use of
clinical guidelines and other possible educational tools,
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related knowledge, clinical decision making, and, ultim-
ately, patient outcomes can help inform education-based
strategies for improving diabetes care in the future.
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